AmerisourceBergen Corp at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 10:00PM GMT
Lisa Christine Gill - JP Morgan Chase & Co, Research Division - Senior Publishing Analyst

Good afternoon. My name is Lisa Gill. I'm the Healthcare Technology and Distribution Analyst with JPMorgan. It is with great pleasure this afternoon that I introduce AmerisourceBergen. With us is CEO, Steve Collis. We will take all questions across the hall in the Georgian room post the presentation. Steve?

Steven H. Collis - AmerisourceBergen Corporation - Chairman, President & CEO

Hi Lisa. Thank you, everyone, for attending. I was worried Sage presented before us and the room was jampacked, and almost everyone left, but I appreciate everyone who came to attend and fill up our chairs. So I thank you here, for being here. And the next slide is my cautionary note regarding forward-looking statements. Any of you can read, pass an ophthalmology exam, you have my great respect. So now I'll move on to my presentation.

AmerisourceBergen, yes, is $175 billion in revenue. We'll be hopefully getting close to $200 billion in revenue soon. That's quite a milestone. It

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot